|
|
||||||||
From the Department of Neurology (Drs. Vig, Subramony, and Desaiah, and Z. Qin), Pathology (Dr. Fratkin) and Surgery (Dr. McDaniel), University of Mississippi Medical Center, Jackson, MS; and the Department of Laboratory Medicine and Pathology (Dr. Burright), Institute of Human Genetics, University of Minnesota, Minneapolis, MN.
Address correspondence and reprint requests to DrS. Vig, Department of Neurology, University of Mississippi Medical Center, Jackson, MS 39216.
Earlier we have shown alterations in immunoreactivity (IR) to the calcium-binding proteins parvalbumin (PV) and calbindin D-28k (CaB) in surviving Purkinje cells of patients with spinocerebellar ataxia-1 (SCA-1). In the present study we determined PV and CaB expression (by immunohistochemical and immunoblot analyses) in Purkinje cells of transgenic mice (TM) expressing the human SCA-1 gene with an expanded (line B05) and normal (line A02) CAG tract, as well as in age-matched nontransgenic mice(nTM). Heterozygotes in the B05 line develop progressive ataxia beginning around 12 weeks of age. A02 animals are phenotypically indistinguishable from wild-type (nontransgenic) animals. In the cerebella of 8-, 9-, and 12-week-old TM-B05 there was a progressive decrease in PV IR in Purkinje cells compared with nTM and TM-A02. Parvalbumin immunostaining in interneurons was well preserved in all groups. A progressive decrease was also observed in CaB IR in Purkinje cells of 8-, 9-, and 12-week-old TM-B05. Cerebellar Purkinje cells of 6-week-old TM-B05, which exhibit no ataxia and even lack demonstrable Purkinje cell loss, also revealed reduction in PV IR. This change was matched by a significant decrease in the amount of cerebellar PV in 6-week-old TM-B05 as determined by Western blot analysis. Calbindin D-28K immunohistochemistry did not detect any marked changes in CaB IR within Purkinje cells at 4 weeks. However, at 6 weeks immunostaining and immunoblot analysis revealed a significant decrease in CaB in TM-B05 compared with controls. These data suggest that decreased levels of calcium-binding proteins in Purkinje cells in SCA-1 transgenic mice may cause alteration in Ca2+ homeostasis.
Supported by a grant to Dr. Vig from the National Ataxia Foundation.
Received June 23, 1997. Accepted in final form June 25, 1997.
This article has been cited by other articles:
![]() |
R. Goold, M. Hubank, A. Hunt, J. Holton, R. P. Menon, T. Revesz, M. Pandolfo, and A. Matilla-Duenas Down-regulation of the dopamine receptor D2 in mice lacking ataxin 1 Hum. Mol. Genet., September 1, 2007; 16(17): 2122 - 2134. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Croci, S.-H. Chung, G. Masserdotti, S. Gianola, A. Bizzoca, G. Gennarini, A. Corradi, F. Rossi, R. Hawkes, and G. G. Consalez A key role for the HLH transcription factor EBF2COE2,O/E-3 in Purkinje neuron migration and cerebellar cortical topography Development, July 15, 2006; 133(14): 2719 - 2729. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Serra, C. E. Byam, J. D. Lande, S. K. Tousey, H. Y. Zoghbi, and H. T. Orr Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice Hum. Mol. Genet., October 1, 2004; 13(20): 2535 - 2543. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Carro, J. L. Trejo, S. Busiguina, and I. Torres-Aleman Circulating Insulin-Like Growth Factor I Mediates the Protective Effects of Physical Exercise against Brain Insults of Different Etiology and Anatomy J. Neurosci., August 1, 2001; 21(15): 5678 - 5684. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |